Position in PVLA
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$152,820
+$28,170 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#147
of 196 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Spire Wealth Management holds $7,680,555 across 34 Biotechnology names. PVLA ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
16,140 | $3,022,698 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | ARGX |
Argenx SE
|
914 | $847,981 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
39,516 | $668,610 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,144 | $559,160 | |
| 6 | EXEL |
Exelixis, Inc.
|
8,794 | $478,481 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
6,303 | $346,665 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
This page
|
1,000 | $152,820 |
All Filings in PVLA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $152,820 | 1,000 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $124,650 | 1,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $104,670 | 1,000 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $63,693 | 1,016 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $56,710 | 2,516 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $70,422 | 2,516 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||